For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| E7389 | E7389 will be administered intravenously on Days 1 and 8 of a 21-day cycle. Initial dose level will be 0.7 mg/m\^2, with planned dose levels of 1.0, 1.4, \& 2.0 mg/m\^2. | None | None | 5 | 15 | 15 | 15 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Febrile Neutropenia | None | Blood and lymphatic system disorders | None | View |
| Abdominal Pain | None | Gastrointestinal disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Myelodysplastic Syndrome | None | Blood and lymphatic system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Neuralgia | None | Nervous system disorders | None | View |
| Neuropathy | None | Nervous system disorders | None | View |
| Neuropathy Peripheral | None | Nervous system disorders | None | View |
| Peripheral Sensory Neuropathy | None | Nervous system disorders | None | View |
| Lacrimation Increased | None | Eye disorders | None | View |
| Cough | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Dyspnea | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Dyspnea Exertional | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Epistaxis | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Constipation | None | Gastrointestinal disorders | None | View |
| Diarrhea | None | Gastrointestinal disorders | None | View |
| Gastritis | None | Gastrointestinal disorders | None | View |
| Gingivitis | None | Gastrointestinal disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Stomatitis | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Alopecia | None | Skin and subcutaneous tissue disorders | None | View |
| Dry Skin | None | Skin and subcutaneous tissue disorders | None | View |
| Hemorrhage Subcutaneous | None | Skin and subcutaneous tissue disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Arthralgia | None | Musculoskeletal and connective tissue disorders | None | View |
| Back Pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Bone Pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Musculoskeletal Pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Myalgia | None | Musculoskeletal and connective tissue disorders | None | View |
| Neck Pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Fatigue | None | General disorders | None | View |
| Edema | None | General disorders | None | View |
| Edema Peripheral | None | General disorders | None | View |
| Pain | None | General disorders | None | View |
| Pyrexia | None | General disorders | None | View |
| Alanine Aminotransferase Increased | None | Investigations | None | View |
| Aspartate Aminotransferase Increased | None | Investigations | None | View |
| Blood Albumin Decreased | None | Investigations | None | View |
| Blood Bilirubin Increased | None | Investigations | None | View |
| Blood Calcium Increased | None | Investigations | None | View |
| Blood Chloride Increased | None | Investigations | None | View |
| Blood Cholesterol Decreased | None | Investigations | None | View |
| Blood Cholesterol Increased | None | Investigations | None | View |
| Blood Creatine Phophokinase Increased | None | Investigations | None | View |
| Blood Creatinine Increased | None | Investigations | None | View |
| Blood Glucose Increased | None | Investigations | None | View |
| Blood Lactate Dehydrogenase Increased | None | Investigations | None | View |
| Blood Potassium Decreased | None | Investigations | None | View |
| Blood Sodium Decreased | None | Investigations | None | View |
| Blood Urea Decreased | None | Investigations | None | View |
| Blood Urea Increased | None | Investigations | None | View |
| C-Reactive Protein Increased | None | Investigations | None | View |
| Electrocardiogram QT Prolonged | None | Investigations | None | View |
| Electrocardiogram ST Segment Depression | None | Investigations | None | View |
| Neutrophil Count Increased | None | Investigations | None | View |
| Platelet Count Decreased | None | Investigations | None | View |
| Protein Total Decreased | None | Investigations | None | View |
| Red Blood Cell Count Decreased | None | Investigations | None | View |
| Weight Decreased | None | Investigations | None | View |
| White Blood Cell Count Decreased | None | Investigations | None | View |
| White Blood Cell Count Increased | None | Investigations | None | View |
| Protein Urine Present | None | Investigations | None | View |
| Blood Alkaline Phosphatase Increased | None | Investigations | None | View |
| Tooth Fracture | None | Injury, poisoning and procedural complications | None | View |
| Febrile Neutropenia | None | Blood and lymphatic system disorders | None | View |
| Nasopharyngitis | None | Infections and infestations | None | View |
| Pharyngitis | None | Injury, poisoning and procedural complications | None | View |
| Pneumonia | None | Infections and infestations | None | View |
| Urinary Tract Infection | None | Infections and infestations | None | View |
| Anorexia | None | Metabolism and nutrition disorders | None | View |
| Convulsion | None | Nervous system disorders | None | View |
| Dysgeusia | None | Nervous system disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Gamma Glutamyltransferase Increased | None | Investigations | None | View |
| Glucose Urine Present | None | Investigations | None | View |
| Blood Urine Present | None | Investigations | None | View |
| Hemoglobin Decreased | None | Investigations | None | View |
| Lymphocyte Count Decreased | None | Investigations | None | View |
| Neutrophil Count Decreased | None | Investigations | None | View |